普拉克索治疗难治性双相抑郁 - Suppr

Suppr

超能文献

Pramipexole in refractory bipolar depression.

作者信息

Goldberg J F, Frye M A, Dunn R T

出版信息

Am J Psychiatry. 1999 May;156(5):798. doi: 10.1176/ajp.156.5.798.

DOI:10.1176/ajp.156.5.798

PMID:10327923

Abstract

摘要

相似文献

Pramipexole in refractory bipolar depression.

Am J Psychiatry. 1999 May;156(5):798. doi: 10.1176/ajp.156.5.798.

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Biol Psychiatry. 2004 Jul 1;56(1):54-60. doi: 10.1016/j.biopsych.2004.03.013.

Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.

Ann Clin Psychiatry. 2000 Sep;12(3):137-40. doi: 10.1023/a:1009060800999.

D-3 receptor agonists: combined action neurologic and neuropsychiatric agents.

J Neurol Sci. 1999 Feb 1;163(1):2-3. doi: 10.1016/s0022-510x(98)00306-2.

Pramipexole treatment for cocaine cravings.

Am J Psychiatry. 1999 Nov;156(11):1834. doi: 10.1176/ajp.156.11.1834.

Mechanism of action of cariprazine.

CNS Spectr. 2016 Apr;21(2):123-7. doi: 10.1017/S1092852916000043. Epub 2016 Mar 9.

Pramipexole for depression.

Am J Psychiatry. 2002 Feb;159(2):320-1. doi: 10.1176/appi.ajp.159.2.320-a.

Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.

Funct Neurol. 2002 Oct-Dec;17(4):199-201.

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.

Am J Psychiatry. 2004 Mar;161(3):564-6. doi: 10.1176/appi.ajp.161.3.564.

Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.

Synapse. 2005 Nov;58(2):122-8. doi: 10.1002/syn.20193.

引用本文的文献

Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis.

Life (Basel). 2023 Apr 19;13(4):1043. doi: 10.3390/life13041043.

Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression.

Neuroimage Clin. 2019;24:101950. doi: 10.1016/j.nicl.2019.101950. Epub 2019 Jul 22.

Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.

Curr Psychiatry Rep. 2013 Aug;15(8):378. doi: 10.1007/s11920-013-0378-z.

Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.

CNS Drugs. 2013 Jul;27(7):515-29. doi: 10.1007/s40263-013-0073-y.

Bipolar depression: an evidence-based approach.

Curr Psychiatry Rep. 2011 Dec;13(6):483-7. doi: 10.1007/s11920-011-0238-7.

New drugs for bipolar disorder.

Curr Psychiatry Rep. 2011 Dec;13(6):513-21. doi: 10.1007/s11920-011-0231-1.

Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

CNS Neurosci Ther. 2010 Jun;16(3):e1-17. doi: 10.1111/j.1755-5949.2010.00146.x. Epub 2010 Apr 8.

Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.

Pharmacoeconomics. 2005;23(12):1257-70. doi: 10.2165/00019053-200523120-00009.

The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.

Psychopharmacology (Berl). 2004 Sep;175(2):163-9. doi: 10.1007/s00213-004-1809-7. Epub 2004 Feb 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验